KF2025#1 Trial: Ketamine, Cannabidiol and Cobicistat Interaction Study

NCT07462559 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Drug Drug Interaction

Interventions

DRUG: Ketamine 10 mg/ml oral solution, UK special
DRUG: Cobisistat Tybost 150 mg
DRUG: Cannabidiol Epidyolex 100 mg/ml

Sponsor

Helsinki University Central Hospital

Collaborators

[object Object]